News | Radiation Oncology | February 07, 2024

Nine-time award winner MOSAIQ Oncology Information System offers clinicians unprecedented levels of automation, mobility and more time with patients

Nine-time award winner MOSAIQ Oncology Information System offers clinicians unprecedented levels of automation, mobility and more time with patients

February 7, 2024 — Elekta announced that its MOSAIQ Oncology Information System (OIS) has earned the “Best in KLAS” designation in the 2024 Best in KLAS: Software and Services Report. MOSAIQ ranked first in the Oncology (Radiation) category. Based on feedback from thousands of providers, awards are based on evaluations collected by KLAS, an independent research firm.

A fixture in many of the world’s leading cancer care facilities, MOSAIQ is the multidisciplinary backbone of the company’s Elekta ONE unified software environment. Elekta ONE brings all Elekta software products, solutions and services under one umbrella and includes radiation therapy planning, comprehensive treatment management and delivery.

"In an era driven by AI, data, and software, we take pride in offering solutions that enable the providers we serve to elevate care for their patients," says Carlos Castilleja, Executive Vice President, Region Americas. “We remain steadfast in our commitment to be a trusted partner and adapt to our customers' evolving needs by providing unparalleled service and support across all of our products, including Elekta ONE.”

Anish Patankar, SVP and Head of Elekta’s Oncology Software Solutions Business Line adds: “The introduction of Elekta ONE, a software as a service (SaaS) offering, demonstrates our focus on personalization, integration and a streamlined user experience that makes it easy for our customers to boost productivity and focus on treating their patients. Winning this prestigious award, and the increased use of MOSAIQ globally, is the result of our software investment in recent years. We see how accelerating innovation is having a direct benefit to healthcare providers and those they treat.”

The 2024 report showed that MOSAIQ outperformed competitors in several categories. User feedback was measured across several areas, including culture, loyalty, operations, product, relationships, and value.

Elekta will receive the award on March 11 during the “Best in KLAS Awards Show” at HIMSS24 in Orlando.

For more information: www.elekta.com/ONE


Related Content

News | Magnetic Resonance Imaging (MRI)

June 26, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for the Magnetom Flow.Ace, its ...

Time June 26, 2025
arrow
News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Image Guided Radiation Therapy (IGRT)

June 25, 2025 — Royal Philips and Indiana-based Methodist Hospitals recently announced the healthcare provider’s ...

Time June 25, 2025
arrow
News | Bone Densitometry Systems

June 19, 2025 — Naitive Technologies has published results demonstrating the diagnostic performance of its AI-powered ...

Time June 18, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
News | Digital Pathology

June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to ...

Time June 12, 2025
arrow
News | Lung Imaging

June 11, 2025 — To prepare healthcare workforces and providers for an AI-driven future, Qure.ai has expanded its Global ...

Time June 11, 2025
arrow
News | Radiology Imaging

June 10, 2025 — CIVIE has announced the official launch of RadPod, an AI-driven, on-demand radiology platform designed ...

Time June 10, 2025
arrow
News | Ultrasound Imaging

June 4, 2025 — RadNet, Inc., a provider of high-quality, cost-effective diagnostic imaging services and digital health ...

Time June 09, 2025
arrow
News | Mammography

June 9, 2025 — A new independent, peer-reviewed study published in the journal Clinical Breast Cancer reinforces the ...

Time June 09, 2025
arrow
Subscribe Now